Abcellera Biologics Inc (ABCL) Stock Price, Quote & News

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 559 9005

Website: www.abcellera.com

Address:

150 West 4th Ave, Vancouver, Canada

sogenerous Dec. 10 at 8:19 PM

$ABCL looking good

0 · Reply

estatebuyersmia Dec. 10 at 8:16 PM

0 · Reply

estatebuyersmia Dec. 10 at 8:15 PM

$ABCL

0 · Reply

Odoji Dec. 10 at 7:56 PM

$ABCL 🙏🎄

0 · Reply

MistyMocha Dec. 10 at 7:33 PM

Whats happening this one right now?!!! $ABCL $FBIO $SNDX $TGTX

0 · Reply

Stocktradesmoon Dec. 10 at 7:22 PM

$ABCL Live feed of Ed at his moms basement

0 · Reply

MoonMagnets Dec. 10 at 6:59 PM

How much volume do you think it takes to halt SBDS up? SBDS has not even 300k shares float and recent news. Hoping for a 300% run on SBDS $SVRE $ABCL $AUR $UPXI $ROKU /

0 · Reply

Hognose Dec. 10 at 5:47 PM

$IBIO called this at $2.20. I would scale out. $ABCL look at

0 · Reply

estatebuyersmia Dec. 10 at 5:22 PM

$ABCL PREDICTION : $ABCL WILL HIT 4 BY DEC 18 OR SOONER

0 · Reply

estatebuyersmia Dec. 10 at 5:21 PM

$ABCL

0 · Reply

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 8, 2025, 1:37 PM EST - 2 days ago

AbCellera Biologics Inc. (ABCL) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Nov 22, 2025, 12:23 AM EST - 18 days ago

AbCellera Biologics Inc. (ABCL) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 10, 2025, 9:00 AM EST - 4 weeks ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 7, 2025, 7:16 PM EST - 4 weeks ago

AbCellera Biologics Inc. (ABCL) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 4 weeks ago

AbCellera Reports Q3 2025 Business Results

Oct 7, 2025, 4:05 PM EDT - 2 months ago

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Oct 6, 2025, 7:35 AM EDT - 2 months ago

AbCellera Biologics: Entering Growth Phase After A Pause

Sep 29, 2025, 4:05 PM EDT - 2 months ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 10, 2025, 9:07 AM EDT - 3 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Aug 27, 2025, 9:00 AM EDT - 3 months ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 12, 2025, 4:05 PM EDT - 4 months ago

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 7, 2025, 7:48 PM EDT - 4 months ago

AbCellera Biologics Inc. (ABCL) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 4 months ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Jul 7, 2025, 4:05 PM EDT - 5 months ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 2, 2025, 6:45 PM EDT - 6 months ago

Why AbCellera Biologics Stock Raced Nearly 6% Higher Today

May 30, 2025, 1:00 PM EDT - 6 months ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 14, 2025, 5:00 PM EDT - 7 months ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 12, 2025, 3:30 PM EDT - 7 months ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 9, 2025, 7:30 PM EDT - 7 months ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 8, 2025, 10:33 PM EDT - 7 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 7 months ago

AbCellera Reports Q1 2025 Business Results

Apr 29, 2025, 3:00 PM EDT - 8 months ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 8, 2025, 4:05 PM EDT - 8 months ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 3, 2025, 4:05 PM EDT - 8 months ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 25, 2025, 4:30 PM EDT - 9 months ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Feb 27, 2025, 11:26 PM EST - 10 months ago

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Full Year 2024 Business Results

Feb 11, 2025, 4:05 PM EST - 10 months ago

AbCellera to Participate at Upcoming Investor Conferences in March

Jan 21, 2025, 4:05 PM EST - 11 months ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 13, 2025, 9:00 AM EST - 11 months ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock

Nov 21, 2024, 4:05 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 7, 2024, 10:05 AM EST - 1 year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 4, 2024, 7:22 PM EST - 1 year ago

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

Oct 22, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition

Oct 4, 2024, 9:00 AM EDT - 1 year ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

Sep 26, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

Aug 29, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in September

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty

Aug 20, 2024, 9:45 AM EDT - 1 year ago

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

GLOB AVDX LRN PGRU

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results

Jul 31, 2024, 9:00 AM EDT - 1 year ago

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

Jul 21, 2024, 5:37 AM EDT - 1 year ago

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

FATE

Jun 25, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

Jun 13, 2024, 5:40 AM EDT - 1 year ago

Down 57%, Is AbCellera Biologics a Buy on the Dip?

May 28, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

May 7, 2024, 11:00 PM EDT - 1 year ago

AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript

sogenerous Dec. 10 at 8:19 PM

$ABCL looking good

0 · Reply

estatebuyersmia Dec. 10 at 8:16 PM

0 · Reply

estatebuyersmia Dec. 10 at 8:15 PM

$ABCL

0 · Reply

Odoji Dec. 10 at 7:56 PM

$ABCL 🙏🎄

0 · Reply

MistyMocha Dec. 10 at 7:33 PM

Whats happening this one right now?!!! $ABCL $FBIO $SNDX $TGTX

0 · Reply

Stocktradesmoon Dec. 10 at 7:22 PM

$ABCL Live feed of Ed at his moms basement

0 · Reply

MoonMagnets Dec. 10 at 6:59 PM

How much volume do you think it takes to halt SBDS up? SBDS has not even 300k shares float and recent news. Hoping for a 300% run on SBDS $SVRE $ABCL $AUR $UPXI $ROKU /

0 · Reply

Hognose Dec. 10 at 5:47 PM

$IBIO called this at $2.20. I would scale out. $ABCL look at

0 · Reply

estatebuyersmia Dec. 10 at 5:22 PM

$ABCL PREDICTION : $ABCL WILL HIT 4 BY DEC 18 OR SOONER

0 · Reply

estatebuyersmia Dec. 10 at 5:21 PM

$ABCL

0 · Reply

estatebuyersmia Dec. 10 at 4:59 PM

$ABCL $RLYB IS MOVING ED... WOW

0 · Reply

Stocktradesmoon Dec. 10 at 4:01 PM

$ABCL $ABCL is looking to complete Wave 2. The 200-day MA $3.65. The 0.618 Fib $3.65. The strongest confluence support level.

0 · Reply

OnChainAce Dec. 10 at 4:42 AM

$ABCL 👀

0 · Reply

DeMampCamp Dec. 10 at 2:53 AM

$ABCL Tax loss season, likely not much moment going to happen right now, but hopefully the markets can cooperate with us to help offset some of the selling! 2026 is the beginning of something special here!

0 · Reply

HedgeAlerts Dec. 9 at 9:45 PM

Hedge Alert Live - Protect Your Portfolio Contract: $ABCL $3.00 Put · DEC 19, 2025 Exp Entry Price: $0.05 - $0.10 Exit Price Target: $0.08 Profit Margin: +64% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com

0 · Reply

Hognose Dec. 9 at 9:35 PM

$AFJK next mover should be $RXRX $IBIO $ABCL or $MDCX

0 · Reply

ispy Dec. 9 at 8:42 PM

$ABCL the ripp is ready kids... Ed's mom called and told me she's loading up here...

0 · Reply

Hognose Dec. 9 at 8:16 PM

$ABCL $MDCX two potential runners. Primed.

0 · Reply

tkstockpicker Dec. 9 at 8:01 PM

$ABCL added

0 · Reply

Stocktradesmoon Dec. 9 at 7:31 PM

$ABCL Nice to see $ABCL continuously making higher lows

0 · Reply

Cello69 Dec. 9 at 7:25 PM

$ABCL Won't do shit until late 1st QTR 2026

3 · Reply

Market Cap	1.07B
Revenue (ttm)	28.83M
Net Income (ttm)	-162.86M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-564.90%
Debt to Equity Ratio	0.00

Volume	2,659,866
Avg Vol	5,185,702
Day's Range	N/A - N/A
Shares Out	299.34M
Stochastic %K	72%
Beta	0.73
Analysts	Strong Sell
Price Target	$9.00